Literature DB >> 31125990

[Drug-drug interactions you should know!]

Niels Voigt, Katharina Ort, Samuel Sossalla.   

Abstract

Drug-drug interactions (DDI) represent a significant problem in modern medicine. The number of patients with multi-morbidity, who take multiple drugs, is constantly increasing (polypharmacy). The related exponential increase in potential DDI is almost incomprehensible. In this article, we review pharmacodynamic DDI and provide clinically relevant examples. In addition, we extensively review pharmakokinetic DDI (e. g. through the cytochrome P450-system or p-glycoproteins) that can modify the plasma concentration of many compounds, thereby also increasing the likelihood of unwanted side effects. Finally we provide tools, which may help clinicians in their daily practice to identify and avoid potential DDI. In the context of an ageing society receiving polypharmacy, a better awareness of DDI and of strategies to prevent them is expected to reduce mortality and morbidity. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31125990     DOI: 10.1055/a-0894-9924

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  3 in total

1.  The risk of polypharmacy, comorbidities and drug-drug interactions in women of childbearing age with multiple sclerosis.

Authors:  Niklas Frahm; Michael Hecker; Silvan Elias Langhorst; Pegah Mashhadiakbar; Marie-Celine Haker; Uwe Klaus Zettl
Journal:  Ther Adv Neurol Disord       Date:  2020-12-19       Impact factor: 6.570

2.  The pharmaceutical excipient PEG400 affect the absorption of baicalein in Caco-2 monolayer model by interacting with UDP-glucuronosyltransferases and efflux transport proteins.

Authors:  Siyuan Cao; Min Zhang; Minyan Yuan; Dan Yang; Mei Zhao; Shuo Zhang; Pengjiao Wang; Rongping Zhang; Xiuli Gao
Journal:  Pharmacol Res Perspect       Date:  2022-02

3.  Associated factors of potential drug-drug interactions and drug-food interactions in patients with multiple sclerosis.

Authors:  Jane Louisa Debus; Paula Bachmann; Niklas Frahm; Pegah Mashhadiakbar; Silvan Elias Langhorst; Barbara Streckenbach; Julia Baldt; Felicita Heidler; Michael Hecker; Uwe Klaus Zettl
Journal:  Ther Adv Chronic Dis       Date:  2022-08-04       Impact factor: 4.970

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.